Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Sea kale root contains glucosinolates that activate phase II detoxification enzymes through the Nrf2 pathway, promoting cellular protection and liver detoxification. Its phenolic compounds, including sinapic and ferulic acids, inhibit NF-κB inflammatory pathways while providing cardiovascular and digestive support.
Reported Benefits (Provisional)
Origin & History
Sea Kale Root (Crambe maritima) is a robust perennial vegetable native to the coastal regions of Europe, including the UK, France, and the Baltic Sea. It thrives in harsh maritime environments, adapting to sandy and saline soils. This root is highly valued in functional nutrition for its unique blend of fiber, glucosinolates, and essential minerals, supporting detoxification and metabolic balance.
Research Narrative (Provisional)
Research on Sea Kale Root highlights its potential for digestive health, liver detoxification, and cardiovascular wellness, largely attributed to its fiber and glucosinolate content. Studies also indicate its immune-supporting and metabolic-balancing properties. While promising, further human clinical trials are needed to fully establish its therapeutic efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamins C, E - Minerals: Potassium, magnesium, calcium, iron - Phytochemicals: Glucosinolates, polyphenols, flavonoids, sulfur-containing compounds - Other: Dietary fiber, inulin
Reported Mechanism (Provisional)
Glucosinolates and their metabolites isothiocyanates (ITCs) activate the Nrf2 pathway, where Nrf2 translocates to the nucleus and binds to antioxidant response elements (AREs), accelerating transcription of protective detoxification genes. Phenolic compounds like sinapic and ferulic acids inhibit NF-κB, suppressing proinflammatory mediators including TNF-α, interleukin-1β, and cyclooxygenase-2. ITCs also inhibit phase I cytochrome P450 enzymes, reducing metabolic activation of carcinogens while inducing cell cycle arrest.
Clinical Narrative (Provisional)
No specific clinical trials on sea kale root have been conducted to date, representing a significant gap in evidence-based therapeutic applications. Related studies on Brassica species show glucosinolate concentrations can increase 15-27% under stress conditions, while inflammatory markers (IL-6, IL-1β, TNFα) were reduced to control levels in animal models. Current therapeutic claims are based on phytochemical analysis and mechanistic studies rather than human clinical data. Further human trials are essential to establish definitive therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.